Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website’s footer revision indicator changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:45:45.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the ALT-803 and nivolumab study is displayed with detailed study design, participant criteria, locations, outcome measures, and record history. It also includes links to the study protocol and informed consent form.
    Difference
    61%
    Check dated 2026-11-11T01:52:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:09:43.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:17:50.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:22:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study page for NCT02523469 now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previously available trial content and documents.
    Difference
    20%
    Check dated 2026-09-23T00:13:01.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.